- Home
- IHT vs RDHL Comparison
IHT vs RDHL Comparison
Compare IHT & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IHT | RDHL |
|---|---|---|
| Founded | 1971 | 2009 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2M | 4.0M |
| IPO Year | 1995 | 2012 |
Fundamental Metrics
Financial Performance| Metric | IHT | RDHL |
|---|---|---|
| Price | $1.34 | $0.65 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 21.9K | ★ 2.4M |
| Earning Date | 05-12-2026 | 04-27-2026 |
| Dividend Yield | ★ 1.77% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $7,600,000.00 | N/A |
| Revenue This Year | N/A | $381.91 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1.33 | N/A |
| 52 Week Low | $0.95 | $0.57 |
| 52 Week High | $4.24 | $2.79 |
Technical Indicators
Market Signals| Indicator | IHT | RDHL |
|---|---|---|
| Relative Strength Index (RSI) | 39.81 | 46.55 |
| Support Level | $1.23 | $0.62 |
| Resistance Level | $1.51 | $0.85 |
| Average True Range (ATR) | 0.10 | 0.11 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 37.18 | 5.98 |
Price Performance
Historical ComparisonAbout IHT InnSuites Hospitality Trust Shares of Beneficial Interest
InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns interests in two hotels, operates and provides management services, and provides trademark license services, for two hotels. The Trust also holds an investment related to clean energy electricity generation technology and manages an option to acquire an investment in an independent boutique hotel reservation and hotel services business.
About RDHL Redhill Biopharma Ltd.
RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.